Comparison of Once-Weekly Trelagliptin Vs. Once-Daily Vildagliptin for HbA1c Reduction in Type 2 Diabetes
Clinical trial NCT06889909 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06889909
- Sponsor
- Lahore General Hospital
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2024-12-15
- Primary completion
- 2025-06-15
- Enrollment
- 102
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.